All PlansCoverageHigh impact
Positive Airway Pressure Devices CPAP BiPAP APAP and Noninvasive Positive Pressure Ventilators (NIV) 1.01.06
Excellus BlueCross BlueShield·NY · Sleep Medicine, Pulmonology, Neurology +2 more·Sleep Medicine
Effective date
Jul 17, 2025
We identified it
Jul 16, 2026
Summary
Excellus BlueCross BlueShield has issued a comprehensive update to its policy on Positive Airway Pressure (PAP) devices covering CPAP, APAP, BPAP, and NIPPV effective July 17, 2025. The policy establishes new clinical criteria for initial 90-day trials, continuation coverage requirements (70% nightly use, 4+ hours per 24-hour period), device replacement standards, and specific indications for each device type. Billing teams must verify medical necessity documentation, compliance metrics, and device failure justification before processing claims for these sleep medicine devices.
Action Required
By July 17, 2025: (1) Billing team must update prior authorization workflows in billing software to enforce the new medical necessity criteria for all PAP device requests: CPAP/APAP require AHI/RDI documentation (either >5 with symptoms/cardiac disease OR ≥15 events/hour); BPAP requires CPAP failure documentation plus specific indications for OSA, central sleep apnea, or chronic respiratory failure; NIPPV requires CPAP and BPAP failure documentation. (2) Coding staff must verify that all CPAP claims (CPT 94660) include documentation of in-person initiation and device approval. (3) Claims processors must enforce continuation coverage denial logic: ALL claims after the 90-day trial require documented evidence of BOTH improved AHI/symptoms AND compliance (70% of nights, ≥4 hours per night over consecutive 30-day period). (4) For device replacement requests (HCPCS E0601), configure system to require documentation of: current device compliance history, malfunction evidence, warranty expiration, and cost-benefit analysis showing repair costs exceed replacement. (5) Providers must be notified via bulletin that CPAP for snoring without OSA (CPT 94660 without qualifying AHI/RDI) will be denied. (6) Front desk and authorization staff should flag all pediatric PAP requests for special review—different criteria apply (failure of adenotonsillectomy, contraindications to surgery, or strong preference for nonsurgical approach, plus AHI ≥5 with symptoms OR normal AHI with symptoms plus hypercarbia documentation). Claims submitted without required compliance data, trial completion evidence, or device necessity justification will be denied.